AERI logo

Aerie Pharmaceuticals (AERI) Working Capital

AERI Annual Working Capital

$230.66 M
+$3.38 M+1.49%

31 December 2021

AERI Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AERI Quarterly Working Capital

$169.48 M
-$22.27 M-11.61%

30 September 2022

AERI Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AERI Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1.5%+7.4%
3 y3 years+36.2%-47.6%
5 y5 years+0.7%-36.0%

AERI Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-21.2%-47.6%

Aerie Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sept 2022
-
$169.48 M(-11.6%)
June 2022
-
$191.75 M(-4.9%)
Mar 2022
-
$201.68 M(-12.6%)
Dec 2021
$230.66 M(+1.5%)
$230.66 M(+46.1%)
Sept 2021
-
$157.82 M(-12.8%)
June 2021
-
$180.93 M(-9.6%)
Mar 2021
-
$200.21 M(-11.9%)
Dec 2020
$227.28 M(-22.3%)
$227.28 M(+10.0%)
Sept 2020
-
$206.57 M(-9.9%)
June 2020
-
$229.22 M(-11.6%)
Mar 2020
-
$259.29 M(-11.4%)
Dec 2019
$292.69 M(+72.8%)
$292.69 M(-9.6%)
Sept 2019
-
$323.66 M(+248.0%)
June 2019
-
$93.00 M(-27.5%)
Mar 2019
-
$128.35 M(-24.2%)
Dec 2018
$169.39 M(-26.0%)
$169.39 M(-20.0%)
Sept 2018
-
$211.80 M(-20.6%)
June 2018
-
$266.70 M(-15.6%)
Mar 2018
-
$316.02 M(+38.0%)
Dec 2017
$228.96 M
$228.96 M(-13.5%)
DateAnnualQuarterly
Sept 2017
-
$264.80 M(-10.6%)
June 2017
-
$296.17 M(+50.6%)
Mar 2017
-
$196.65 M(-9.9%)
Dec 2016
$218.32 M(+80.0%)
$218.32 M(-10.0%)
Sept 2016
-
$242.44 M(+157.8%)
June 2016
-
$94.06 M(-10.1%)
Mar 2016
-
$104.64 M(-13.7%)
Dec 2015
$121.31 M(-8.2%)
$121.31 M(-12.1%)
Sept 2015
-
$138.07 M(-2.5%)
June 2015
-
$141.65 M(-4.7%)
Mar 2015
-
$148.56 M(+12.4%)
Dec 2014
$132.16 M(+97.9%)
$132.16 M(-19.8%)
Sept 2014
-
$164.72 M(+214.3%)
June 2014
-
$52.41 M(-15.6%)
Mar 2014
-
$62.09 M(-7.0%)
Dec 2013
$66.78 M(-9052.4%)
$66.78 M(-704.6%)
Sept 2013
-
-$11.05 M(+33.1%)
June 2013
-
-$8.30 M(+1012.9%)
Dec 2012
-$746.00 K(-106.0%)
-$746.00 K
Dec 2011
$12.49 M
-

FAQ

  • What is Aerie Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Aerie Pharmaceuticals?
  • What is Aerie Pharmaceuticals annual working capital year-on-year change?
  • What is Aerie Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Aerie Pharmaceuticals?
  • What is Aerie Pharmaceuticals quarterly working capital year-on-year change?

What is Aerie Pharmaceuticals annual working capital?

The current annual working capital of AERI is $230.66 M

What is the all time high annual working capital for Aerie Pharmaceuticals?

Aerie Pharmaceuticals all-time high annual working capital is $292.69 M

What is Aerie Pharmaceuticals annual working capital year-on-year change?

Over the past year, AERI annual working capital has changed by +$3.38 M (+1.49%)

What is Aerie Pharmaceuticals quarterly working capital?

The current quarterly working capital of AERI is $169.48 M

What is the all time high quarterly working capital for Aerie Pharmaceuticals?

Aerie Pharmaceuticals all-time high quarterly working capital is $323.66 M

What is Aerie Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, AERI quarterly working capital has changed by +$11.66 M (+7.39%)